JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 47:1188-1195, doi:10.1016/j.jacc.2005.10.062 (Published online 21 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.10.062v1
47/6/1188    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schindler, T. H.
Right arrow Articles by Schelbert, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schindler, T. H.
Right arrow Articles by Schelbert, H. R.

CLINICAL RESEARCH

Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function

Thomas H. Schindler, MD*, Jerson Cardenas, MD*, John O. Prior, MD, PhD*, Alvaro D. Facta, MD*, Michael C. Kreissl, MD*, Xiao-Li Zhang, MD, PhD*, James Sayre, PhD*, Magnus Dahlbom, PhD*, Julio Licinio, MD{dagger} and Heinrich R. Schelbert, MD, PhD*,*

* Department of Molecular and Medical Pharmacology
{dagger} Department of Psychiatry and Biobehavioral Science and Medicine/Endocrinology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, California

Manuscript received August 6, 2005; revised manuscript received September 30, 2005, accepted October 10, 2005.

* Reprint requests and correspondence: Dr. Heinrich H. Schelbert, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 23-120 CHS, Box 173517, Los Angeles, California 90095-1735 (Email: hschelbert{at}mednet.ucla.edu).

OBJECTIVES: We sought to evaluate effects of obesity, insulin resistance, and inflammation on coronary circulatory function and its relationship to leptin plasma levels.

BACKGROUND: It is not known whether obesity, commonly paralleled by insulin resistance, inflammation, and leptin, is independently associated with coronary circulatory dysfunction.

METHODS: Myocardial blood flow (MBF) responses to cold pressor test (CPT) and pharmacologic vasodilation was measured with positron emission tomography and 13N-ammonia. Study participants were divided into three groups based on their body mass index (BMI, kg/m2): control, 20 ≤ BMI <25 (n = 19); overweight, 25 ≤ BMI <30 (n = 21); and obese, BMI >30 (n = 32).

RESULTS: Body mass index was significantly correlated to the Homeostasis Model Assessment Index of insulin resistance and C-reactive protein levels (r = 0.60 and r = 0.47, p < 0.0001). Compared with control subjects, endothelium-related change in MBF ({Delta}MBF) to CPT progressively declined in overweight and obese groups (0.32 ± 0.09 vs. 0.21 ± 0.19 and 0.07 ± 0.16 ml/g/min; p < 0.03 and p < 0.0001). The dipyridamole-induced total vasodilator capacity was significantly lower in obese than in control subjects (1.77 ± 0.51 vs. 2.04 ± 0.37 ml/g/min, p < 0.02). On multivariate analysis, BMI (p < 0.012) and age (p < 0.035) were significant independent predictors of {Delta}MBF. Finally, only in the obese group leptin plasma levels significantly correlated with {Delta}MBF (r = 0.37, p < 0.036).

CONCLUSIONS: Increased body weight is independently associated with abnormal coronary circulatory function that progresses from an impairment in endothelium-related coronary vasomotion in overweight individuals to an impairment of the total vasodilator capacity in obese individuals. The findings that elevated leptin plasma levels in patients that are obese might exert beneficial effects on the coronary endothelium to counterbalance the adverse effects of increases in body weight on coronary circulatory function should be tested.

Abbreviations and Acronyms
  ANOVA = analysis of variance
  BMI = body mass index
  CAD = coronary artery disease
  CPT = cold pressor test
  CRP = C-reactive protein
  CVR = coronary vascular resistance
  ECG = electrocardiogram
  HDL = high-density lipoprotein
  HOMA = Homeostasis Model Assessment
  LDL = low-density lipoprotein
  MBF = myocardial blood flow
  PET = positron emission tomography
  ROS = reactive oxygen species
  RPP = rate-pressure product
  WHR = waist-hip ratio




This article has been cited by other articles:


Home page
J. Nutr.Home page
I. Torre-Villalvazo, A. R. Tovar, V. E. Ramos-Barragan, M. A. Cerbon-Cervantes, and N. Torres
Soy Protein Ameliorates Metabolic Abnormalities in Liver and Adipose Tissue of Rats Fed a High Fat Diet
J. Nutr., March 1, 2008; 138(3): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Johannsson, T. Henriksen, and P. O. Iversen
Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1563 - R1568.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T H Schindler, A D Facta, J O Prior, J Cadenas, W A Hsueh, M J Quinones, and H R Schelbert
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes
Heart, March 1, 2007; 93(3): 345 - 349.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann
Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET
J. Nucl. Med., September 1, 2006; 47(9): 1420 - 1426.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.